CURRENT MEDICAL AND DRUG RESEARCH

Articles>> Volume 2 Issue 2, 2018

CURRENT MEDICAL AND DRUG RESEARCH
A clinical trial for the efficacy of Ashwagandha powder in obsessive-compulsive disorder
Neha Saini
Curr Med Drug Res 2 (2): Art. ID 188 (2018)
Obsessive-compulsive disorder (OCD) is a ceaseless mental issue that is causally connected to the dysregulation of the serotonergic framework. OCD is believed to be a standout amongst the most obstinate and impairing nervousness related mental issues in the network, described by steady and pain causing considerations (obsessions), which are egodystonic and apparently intentional conduct (impulses). The present examination has assessed the viability of Ashwagandha choorna (powder). The powder at a dose of 4.5 g, twice a day, after sustenance, nearby nectar was given to them orally for multi-month. In the wake of completing treatment, follow-up was done. Three examinations of before treatment, after treatment and after improvement were done. Criteria of examination relied upon the scoring of Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and Yale-Brown Obsessive Compulsive Symptom Checklist was used to perceive signs. Paired 't' test was used for real appraisal. The results showed that Ashwagandha powder gave 24.66% of help (p<0.001) on Y-BOCS, which was considered as a clinically non-significant.

Related Article

Mucoadhesive assessment – An encyclopedic review
R. Semwal, R. B. Semwal and D. K. Semwal
Curr Med Drug Res 2 (2): Art. ID 187 (2018)

Antimicrobial activity of a new entomopathogenic bacteria Acinetobacter
I. Deepa and C. Mohandas
Curr Med Drug Res 2 (2): Art. ID 189 (2018)

Hazards of cosmetics and the role of Ayurveda in skincare
J. K. Painuli and Mayank Bhatkoti
Curr Med Drug Res 2 (2): Art. ID 190 (2018)

Abstracting and Indexing